Charlie's Holdings, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $46.8M
- Price
- $0.1669
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 5.6K
About
Charlie's Holdings, Inc., along with its affiliated companies, specializes in the creation, promotion, and worldwide distribution of vapor products containing nicotine. Its merchandise is supplied to approximately 80 nations, including prominent markets such as the United Kingdom, Italy, Spain, New Zealand, Australia, and Canada, through a multi-channel network comprising wholesale partners, specialized retail outlets, and independent online sellers. The corporation was formerly known as True Drinks Holdings, Inc. before rebranding as Charlie's Holdings, Inc. Established in 2014, the firm's principal operations are based in Costa Mesa, California.
Quick stats
Shares outstanding280.6M
Computed float133.1M
Float / shares47.4%
Cash runway (months)-3.1
Key info
SectorConsumer Defensive
IndustryTobacco
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001134765
AI Summary
AI-generated1/16
standardbullishregulatory
Charlie's Holdings (OTCQB: CHUC) Applauds the Trump Administration’s Plans to Re-vamp the FDA Authorization Process for Flavored Vapes
Charlie's Holdings applauded reports that the Trump administration plans to revise FDA rules governing PMTA applications, which could make it easier and faster for flavored vapes like its own to win authorization.
The FDA is reportedly expected to revisit a 2021 rule governing the PMTA process in coming days, per The Wall Street Journal. Charlie's has been pursuing marketing authorization for tobacco-derived nicotine products since September 2020 and synthetic nicotine products since May 2022.
The company retains 678 timely-filed PMTA assets after selling 16 PACHA brand PMTA products to one of the world's largest tobacco companies in 2025, and management believes a streamlined pathway would make its PACHA portfolio among the most valuable in the industry.
Red flags
- Regulatory change is only reported, not announced by the FDA; no final rule or timeline exists
- Sentiment-heavy self-promotional release from a micro-cap issuer relying on unnamed sources